baber/WOPTO huggingface dataset:
Patent CA-2455208-A1 (CA)
Title: Method of encapsulating an active substance
Inventor: ROLFES HEIDI
IPC: A61K9/16
Filed: 2002-05-28
Abstract: The invention provides a method of encapsulating an active substance in an interpolymer complex, to make an encapsulated product in particulate form. The method comprises forming a mixture of a supercritical fluid, an interpolymer complex and an active substance and then causing or allowing the interpolymer complex to encapsulate the active substance. The encapsulated product is then separated from the supercritical fluid and, if necessary, the product is subjected to size reduction to ontain particles in which the active substance is encapsulated by the interpolymer complex.
Patent CA-2457489-A1 (CA)
Inventor: MARTIN GORDON DAVID
IPC: A22C13/00
Filed: 2002-08-23
Abstract: Extruded tubular casing for food-products (such as sausages) is made from an extrudable gel. The gel comprises collagen, fat and a humectant. The collagen content consists essentially of porcine collagen, and the fat content is reduced below that of natural porcine skin or hide. Generally, the ratio of collagen to fat is at least 2.0 to 1 and especially above 10 to 1.
Patent CA-2459887-A1 (CA)
Title: Carba-sugar amine derivative and glycolipid metabolic disorder treating agent containing the same as active ingredient
Inventor: OGAWA SEIICHIRO
IPC: C07C271/24
Filed: 2002-09-02
Abstract: Carba-sugar amine derivatives represented by the general formula (1) or (2) are useful as active ingredients of .beta.-galactosidase inhibitors or treating agents for disorder of glycolipid metabolism: (1) (2) wherein R1 an d R2 are each independently H, alkyl, acyl, aryl, or aralkyl, with the proviso that both are not hydrogen; R3, R4, R5, and R6 are each independently hydrox yl or substituted hydroxyl; R7 is alkyl; and R8, R9, R10, and R11 are each independently hydroxyl or substituted hydroxyl.
Patent CA-2460218-A1 (CA)
Inventor: MARRS LEO RICHARD JR
IPC: G06Q30/02
Filed: 2002-09-12
Abstract: Published without an Abstract
Patent CA-2460290-A1 (CA)
Inventor: CAIN RUSSELL P
IPC: G01M3/02
Filed: 2002-11-01
Abstract: L'invention concerne certaines techniques destinées à surveiller l'état d'un récipient, lesquelles consistent à fixer une série de capteurs constituée d'au moins un capteur à une enveloppe extérieure du récipient, et à fournir de la puissance à cette série de capteurs, en fonction d'une différence de température entre une température d'un fluide contenu dans le récipient et une température ambiante à l'extérieur du récipient. Certaines techniques consistent à fixer une série de capteurs par serrage d'une ceinture autour du récipient et par fixation rigide de deux extrémités d'une jauge de déformation située dans la série de capteurs à l'enveloppe extérieure du récipient, par exemple sur des côtés opposés d'une ligne de soudure joignant deux sections du récipient. Ces techniques permettent qu'un pipeline soit facilement instrumenté et surveillé à distance, ce qui permet de réduire les coûts de main d'oeuvre pour effectuer des inspections manuelles, les risques de blessures dues à des inspections manuelles effectuées dans des conditions atmosphériques dangereuses, ainsi que la probabilité de fuites non détectées.
Patent CA-2461157-A1 (CA)
Title: Sustained release heterodisperse hydrogel systems - amorphous drugs
Inventor: BAICHWALL ANAND R
IPC: A61K47/30
Filed: 1997-04-18
Abstract: Sustained release oral solid dosage forms comprising agglomerated particles of a therapeutically active medicament in amorphous form, a gelling agent, an ionizable gel strength enhancing agent and an inert diluent, as well as processes for preparing and using the same are disclosed. The sustained release oral solid dosage forms are useful in the treatment of hypertension in human patients.
Patent CA-2462126-A1 (CA)
Title: Rubber composition, pneumatic tire and method of producing the same
Inventor: KUROKAWA MAKOTO
IPC: B29D30/52
Filed: 2002-09-27
Abstract: A rubber composition capable of providing a large frictional force, for example, against an object having a surface with a low coefficient of fricti on by forming the composition with foam rubber in appropriate foam condition, a pneumatic tire, particularly, a winter tire such as a studless tire having a grip force on the surfaces of an iced road and a snowed road increased to increase a steering stability such as a braking performance and a turning performance by applying the rubber composition to the upper layer rubber par t of a tread rubber forming at least a tread face, and a method of manufacturi ng the pneumatic tire, the rubber composition (1) characterized by comprising foam rubber substantially extending continuously along a specified direction (4) and having continuous air bubbles (6) sealed therein by resin protective membrane (5).
Patent CA-2462615-A1 (CA)
Title: Promoters for regulation of gene expression in plant roots
Inventor: SKALLA DALE
IPC: C12N15/87
Filed: 2002-11-04
Abstract: The present invention is directed to promoters isolated from maize and functional equivalents thereto. The promoters of the present invention have particular utility in driving root-specific expression of heterologous genes that impart increased agronomic, horticultural and/or pesticidal characteristics to a given promoters of the invention and transformed plant tissues containing DNA molecules comprising a promoter of the invention operably linked to a heterologous gene or genes, and seeds thereof.
Patent CA-2466203-A1 (CA)
Title: Cross-species somatic cell nuclear transfer using rabbit oocyte
Inventor: CHEN YING
IPC: A61K35/48
Filed: 2001-11-06
Abstract: The present invention discloses a method for preparing somatic embryo, which comprises planting a nuclear donor animal cell or its cell nucleus into an enucleate oocyte derived from a same or different animal species to the nuclear donor animal so as to form a nuclear transfer unit, and developing into somatic embryo under the suitable condition; as well as the uses of the somatic embryo obtained by this method.
Patent CA-2467205-A1 (CA)
Title: Tampon with non-aggressive, fluid wicking overwrap
Inventor: GILBERT STEVEN RAY
IPC: A61F13/20
Filed: 2002-11-14
Abstract: An improved absorbent catamenial tampon having a non-aggressive fluid wickin g overwrap, which aids in fluid acquisition while not aggressively adhering to tissue is presented. This tampon comprises a generally elongated absorbent member and an overwrap substantially covering the exterior surface of the generally elongated absorbent member, wherein the overwrap is fluid wicking and has an Agar Shear Force of no more than about 90 grams per inch of material width.
Patent CA-2467231-A1 (CA)
Inventor: MEYER FRANK
IPC: E01B7/22
Filed: 2004-05-13
Abstract: A railroad switch actuator has a transversely extending box sleeper having a pair of ends, adapted to be secured to a pair of longitudinally extending fixed rolling rails, and adapted to slidably support a pair of longitudinally extending and transversely shiftable switch tongues. A switch rod extends transversely in the box sleeper, is connected to the tongues, is centered on a transverse axis, and is displaceable along the transverse axis to shift the tongues. A drive having an output shaft is supported on one end of the sleeper by a hinge for pivotal movement between a down position outboard of the one sleeper end and with the output shaft axially aligned with the switch rod and an up position between the sleeper ends.
Patent CA-2468683-A1 (CA)
Title: Safety syringe with re-usable main parts, method for disposal of a needle into a container and container for disposable parts
Inventor: SEGAL ALAN JULIAN
IPC: A61M5/32
Filed: 2002-11-29
Abstract: A syringe has a barrel (1) to receive a cartridge (31). The barrel (1) has a front end portion (6) to which a needle (32) is connected for engagement with the cartridge. At its rear end the barrel (1) has a plunger mechanism. A  sleeve (15) is slidably mounted on the barrel and can be pushed forwards to sheath the needle. The needle (32) is mounted on the barrel (1) via a push-fit mounting device (22, 34). The needle (32) can be removed for disposal in a container (35) by inserting the syringe into a tube (40) on top of the container so that the protective needle sleeve (15) is pushed back and the needle (32) and mounting device (22, 34) pass through a collar (41) of gripping fingers (42) at an inner end of the tube (40). The fingers (42) catch behind the mounting device (22, 34) so that this is pulled off to drop into the container (35) with the needle (32) when the syringe is withdrawn from the tube. The mounting device (22, 34) may be defined by an adaptor cap (22) on to which a hub (34) of the needle (32) is screwed. The sleeve (15) is mounted on the barrel (1) so as to be guided longitudinally by interengagement of grooves on the sleeve (15) and ridges (12) on the barrel (1). The sleeve (15) can be locked in forward and rearward positions by means of a rotatable collar (17) mounted at the rearward end of the sleeve (15).
Patent CA-2469966-A1 (CA)
Inventor: APPLER PAUL
IPC: F25B45/00
Filed: 2004-06-04
Abstract: The use of sealants based on organosilanes for refrigeration and air conditioning systems is made possible by control of the rate of introduction and viscosity of the sealant mixture within certain ranges. An appropriate choice of organosilane sealant is made to allow effective sealing of small pinhole size leaks in the air conditioning or refrigeration system. The organosilver is then combined with a miscible lubricant at particular ratios to provide the prope r mixture viscosity for injection into the refrigerant system to prevent bearing seizure. specific orifice sizes are selected for an apparatus to ensure that the composition is injected at the flow rate s required to prevent liquid slugging and subsequent compressor shutdown or failure. In addition, effective introduction of the mixture requires certain procedures be performed. Injection procedures are also described that prevent temporary or catastrophic equipment shutdown.</S DOAB>
Patent CA-2472241-A1 (CA)
Title: Utilisation de melagatrane dans la fabrication d'un medicament destine au traitement du diabete mellitus de type i
Inventor: NILSSON BO
IPC: A61P3/10
Filed: 2003-01-21
Abstract: La présente invention concerne l'utilisation de mélagatrane ou d'un dérivé de ce composé répondant aux normes pharmaceutiques, dans la fabrication d'un médicament destiné au traitement du diabète de type I.
Patent CA-2473103-A1 (CA)
Title: Filtre en forme de disque
Inventor: UNGS MARK T
IPC: A61B17/00
Filed: 2003-01-02
Abstract: L'invention concerne un filtre de protection distal et un procédé d'utilisation de ce filtre. Un filtre de protection distal peut être relié à un arbre allongé. Ce filtre comprend un matériau de filtre relié à une ossature de filtre. La forme du filtre peut être généralement cylindrique ou le filtre peut se présenter sous forme de disque. Le matériau de filtre peut permettre de capturer des débris emboliques générés pendant une intervention intravasculaire.
Patent CA-2474653-A1 (CA)
Title: Attachment for a cigarette box
Inventor: BAHAR REUBEN
IPC: B65D25/20
Filed: 2003-02-14
Abstract: A holding device (10) for keeping a cigarette lighter (17) and other compact objects in an abutting manner to a cigarette box (16). The holding device (10) is attached to a medium (1) which contains a message (12). Once attached to the cigarette box (16), the holding device (10) may grip a user's peripheral items close to the box (16), while displaying the message (12) resident on the medium (1). In this respect, the user would be able to keep their items within the close reach. Additionally, the user and others would be subject to viewing the message whenever the medium (1) is exposed. The medium (1) may further be made independent of the holding device (10) and attachable to the cigarette box (16) for the sole purpose of conveying the message contained therein.
Patent CA-2474768-A1 (CA)
Inventor: EASTWOOD JAMES E
IPC: H04L29/06
Filed: 2002-11-22
Abstract: A mobile IP registration solution for mobile nodes (108-111) of a wireless communication system (100). A mobile node receives an IP address of a foreign agent from a control message while attempting (304) to acquire a channel.  Substantially immediately upon acquiring (306) a channel, the mobile node determines (308) whether to send a proxy MIP advertisement. If not, the mobile node retrieves (310) the foreign agent IP address and forwards (312) it to a processing element. If so, the mobile node retrieves (314) the foreign agent IP address and a static capabilities list associated with the foreign agent, constructs (316) a proxy MIP advertisement and forwards (318) it to a processing element. Upon receiving the foreign agent IP address or proxy MIP  advertisement, the processing element constructs (320) a mobile IP  registration request using the foreign agent IP address. The registration request is sent (322) to a home agent (130).
Patent CA-2478150-A1 (CA)
Title: Vehicle mounted animal alerting device
Inventor: EWERT ROGER D
IPC: A01M29/16
Filed: 2004-08-17
Abstract: An animal alerting device system and method for mounting in a vehicle produces a sound that stimulates an alertness response in large animals to reduce the likelihood that the animals will run into a roadway and cause an animal-vehicle crash. The sound produced by the device is a random sound pattern in an audible frequency range. The volume of the sound produced is automatically adjusted for vehicle speed.      Different sound patterns may be produced automatically based on different geographical locations of the vehicle in which the device is mounted.
Patent CA-2481838-A1 (CA)
Inventor: PERVAN DARKO
IPC: B32B21/02
Filed: 2003-04-08
Abstract: Floorboards for making a floating floor have a core (30) which comprises at least two layers of material (L1, L2), which are arranged at different distances from the surface layer (31), and which differ in respect of materi al properties or material composition. Semi manufactures for making such floorboards are also disclosed.
Patent CA-2482231-A1 (CA)
Inventor: THEKKEKANDAM JOSEPH T
IPC: C11D3/37
Filed: 2003-04-07
Abstract: A low-foaming, liquid composition is disclosed. The detergent comprises water, a combination of high-foaming surfactants including linear dodecyl benzene sulfonic acid, nonyl phenoxy ethoxylate and an ethoxylated alcohol containing from about 9 to 15 carbon atoms, at least one pH control agent to provide a pH  from about 6.0 to about 10.5 and at least one control agent. Methods of making and using the low-foaming, liquid composition are also disclosed.
Patent CA-2483188-A1 (CA)
Inventor: KOYANAGI KAORU
IPC: H02J3/00
Filed: 2003-04-21
Abstract: A system for on-line dynamic screening of contingencies comprising postulate d disturbances which an electric power system may experience, the system comprising a dynamic contingency screening program for evaluating a pluralit y of contingencies with a plurality of contingency classifiers based on the method of finding the controlling unstable equilibrium point of the power system known as the boundary of stability region based controlling unstable equilibrium point method by sequentially applying the contingencies to a network islanding problem classifier, SEP (stable equlibrium point) problem classifier, a large stability regions classifier, an exist point problem classifier, a ray adjustment problem classifier, an energy function problem classifier, a CUEP (convergence unstable equilibrium point) convergence problem classifier, and a controlling UEP(unstable equilibrium point) classifier to form a first group of stable contingencies and a second group of unstable or undecided contingencies, and a time-domain simulation program fo r determining which of the second group of contingencies are unstable.
Patent CA-2484556-A1 (CA)
Inventor: ROSEN CRAIG A
IPC: C12N15/62
Filed: 2002-12-23
Abstract: The present invention encompasses albumin fusion proteins. Nucleic acid molecules encoding the albumin fusion proteins of the invention are also encompassed by the invention, as are vectors containing these nucleic acids, host cells transformed with these nucleic acids vectors, and methods of maki ng the albumin fusion proteins of the invention and using these nucleic acids, vectors, and/or host cells. Additionally the present invention encompasses pharmaceutical compositions comprising albumin fusion proteins and methods o f treating or preventing diseases, disorders or conditions related to diabetes mellitus using albumin fusion proteins of the invention.
Patent CA-2486509-A1 (CA)
Title: Seamless hair extension system and method of use
Inventor: STHAIR OKYO
IPC: A41G5/00
Filed: 2004-11-01
Abstract: The present invention consists of a seamless self adhesive hair extension and a method of attaching them to the head of a wearer. The seamless self adhesive hair extensions is comprised of a plurality of either natural or synthetic hair strands attached to a base support made of polyurethane which has a rectangular strip of double sided self adhesive tape with a removable backing as the fastener. The method of use consists of separating a users hair along a part line into an upper portion and a lower portion wherein the upper portion and lower portion are temporarily swept up and away from the part line. Another double sided rectangular strip of self adhesive tape is placed along the lower portion part line approximately a 1/4" from the scalp onto the wearers natural hair, then withdrawing alternating 1/4" strands of the wearers natural hair from the upper portion hair above the part line, the strands or rows will be laved upon the double sided self adhesive tape. The removable backing is removed from the tape that is attached to the hair extension or ventilated poly strip exposing the self adhesive tape; said self adhesive hair extension or ventilated poly strip is applied to the other double face tape on the wearers head which contains said strands, or rows of the wearers natural hair.
Patent CA-2487010-A1 (CA)
Title: Water contaminant indicators
Inventor: LYNCH TONI L
IPC: C02F1/28
Filed: 2004-11-08
Abstract: A filtering device for a gravity-flow liquid treatment system includes a first filter component that can be either exposed or adjacent to a substantially transparent region in at least a portion of a filter housing. The first filter component is capable of providing a visual indication of exposure to at least one contaminant. The contaminants for which the first filter component can indicate exposure include particles, inorganic, and organic contamination. Particle contamination is indicated by a change in color of the first filter component through particle collection. Inorganic and organic contaminants are indicated by reaction with at least one agent capable of undergoing a color-change reaction in response to at least one contaminant. Water treatment systems and filtration devices that include at least one agent capable of undergoing a color-change reaction and thus give a visual indication of exposure to at least one contaminant for use in both gravity-driven and pressure-driven environments are also described.
Patent CA-2488025-A1 (CA)
Inventor: MORSE RICK JAMES
IPC: E04F13/08
Filed: 2004-11-22
Abstract: A generally rectangular siding panel is provided having a front and rear faces, The rear face has a first area proximate to a top end of the rear face and shaped such that at least a portion of the area sits substantially flush with a portion of a vertical wall when the siding panel is secured to the vertical wall and angled to overlap at least a portion of a second siding panel secured to the vertical wall.
Patent CA-2489025-A1 (CA)
Inventor: SAHLIN PER-OLOF
IPC: D21G9/00
Filed: 2003-06-12
Abstract: A process is modeled by a dynamic model, handling time dependent relations between manipulated variables of different process sections (10A-D) and measured process output variables. Suggested input trajectories for manipulated variables for a subsequent time period are obtained by optimizing an objective function over a prediction time period, under constraints imposed by the dynamic process model and/or preferably a production plan for the same period. The objective function comprises relations involving predictions of controlled process output variables as a function of time using the process model, based on the present measurements, preferably by a state estimation procedure. By the use of a prediction horizon, also planned future operational changes can be prepared for, reducing any induced fluctuations. In pulp and paper processes, process output variables associated with chemical additives can be used, adapting the optimization to handle chemical additives aspects.
Patent CA-2489902-A1 (CA)
Title: Thiazole derivatives as phosphodiesterase iv inhibitors
Inventor: EGGENWEILER HANS-MICHAEL
IPC: A61P25/00
Filed: 2003-04-28
Abstract: Thiazole derivatives of the formula I   (see formula I) in which R1 and R2 are each, independently of one another, H, OH, OR8, -SR8, -SOR8, -SO2R8 or Hal; R1 and R2 together are alternatively -OCH2O- or -OCH2CH2O-; R3 and R3' are each, independently of one another, H, A"R7, COA"R7, COOA'R7, CONH2, CONHA"R7, CON(A"R7)(A"'R7), CONR10Het, NH2, NHA"R7, N(A"R7)(A"'R7), NCOA"R7 or NCOOA"R7; V and W are oxygen or hydrogen substituents; B is an optionally substituted aromatic isocyclic or heterocyclic radical; X is N or CR3' ; R7 is H, COOH, COOA, CON H2, CONHA, CONAA', NH2, NHA, NAA', NCOA, NCOOA, OH or OA; R8 is A, cycloalkyl, alkylenecycloalkyl or alkenyl; Y is alkylene or alkenylene; in which one, two or three CH2 groups may be replaced and/or 1-7 H atoms may be replaced; A and A' are each, independently of one another, alkyl or alkenyl, in which one, two or three CH2 groups may be replaced and/or 1-7 H atoms may be replaced, or aryl or Het;    A and A' together are alternatively an alkylene chain, in which one, two or three CH2 groups may be replaced; A" and A"' are each, independently of one another, absent, alkylene, alkenylene or cycloalkylene, in which one, two or three CH2 groups may be replaced and/or 1-7 H atoms may be replaced; A" and A"' together are alternatively an alkylene chain, in which one, two or three CH2 groups may be replaced; aryl is optionally substituted phenyl, naphthyl, fluorenyl or biphenyl; Het is an optionally substituted monocyclic or bicyclic saturated, unsaturated or aromatic heterocyclic ring having 1 or 2 N, O and/or S atoms; and Hal is F, Cl, Br or I act as phosphodiesterase IV inhibitors and can be employed for the treatment of osteoporosis, tumours, cachexia, atherosclerosis, rheumatoid arthritis, multiple sclerosis, diabetes mellitus, inflammatory processes, allergies, asthma, autoimmune diseases, myocardial diseases and AIDS.